AVBP - ArriVent BioPharma, Inc. Common Stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.00
DETAILS
HIGH:
$45.00
LOW:
$45.00
MEDIAN:
$45.00
CONSENSUS:
$45.00
UPSIDE:
68.35%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-02-02 | LaChapelle Robin | officer: Chief Operating Officer | A-Award | 130,000 | $22.67 | $2.9M |
| 2026-02-02 | Lutzker Stuart | director, officer: President of R&D | A-Award | 150,000 | $22.67 | $3.4M |
| 2026-02-02 | Kung Winston | officer: Chief Financial Officer | A-Award | 140,000 | $22.67 | $3.2M |
| 2026-02-02 | Yao Zhengbin | director, officer: President and CEO | A-Award | 550,000 | $22.67 | $12.5M |
| 2026-02-02 | Kastenmayer James Paul | officer: General Counsel | A-Award | 130,000 | $22.67 | $2.9M |
| 2025-12-10 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | SELL | 555,555 | $23.37 | $13.0M |
| 2025-07-11 | LaChapelle Robin | officer: Chief Operating Officer | M-Exempt | 6,503 | $2.28 | $15K |
| 2025-07-11 | LaChapelle Robin | officer: Chief Operating Officer | M-Exempt | 2,050 | $2.28 | $5K |
| 2025-07-11 | LaChapelle Robin | officer: Chief Operating Officer | M-Exempt | 2,600 | $2.28 | $6K |
| 2025-06-18 | Parsey Merdad | director | A-Award | 15,502 | $24.89 | $386K |
| 2025-06-18 | Peterson Kristine | director | A-Award | 15,502 | $24.89 | $386K |
| 2025-06-18 | Nolet Chris | director | A-Award | 15,502 | $24.89 | $386K |
| 2025-06-18 | Hohneker John | director | A-Award | 15,502 | $24.89 | $386K |
| 2025-04-28 | Parsey Merdad | director: | ? | -- | -- | -- |
| 2025-04-28 | Parsey Merdad | director | A-Award | 28,346 | $20.92 | $593K |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | C-Conversion | 55,000,000 | -- | -- |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | C-Conversion | 313,076 | -- | -- |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | C-Conversion | 3,616,041 | -- | -- |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | C-Conversion | 4,761,903 | -- | -- |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | BUY | 555,555 | $18.00 | $10.0M |
| 2024-01-30 | ORBIMED ADVISORS LLC | director, 10 percent owner: | BUY | 222,222 | $18.00 | $4.0M |
| 2024-01-30 | ORBIMED ADVISORS LLC | director, 10 percent owner: | C-Conversion | 821,827 | -- | -- |
| 2024-01-30 | ORBIMED ADVISORS LLC | director, 10 percent owner: | C-Conversion | 469,615 | -- | -- |
| 2024-01-30 | GORDON CARL L | director, 10 percent owner: | BUY | 222,222 | $18.00 | $4.0M |
| 2024-01-30 | GORDON CARL L | director, 10 percent owner: | C-Conversion | 821,827 | -- | -- |